Trials / Unknown
UnknownNCT04029181
ImmunoPET With an Anti-CD8 Imaging Agent
ImmunoPET Imaging With ZED88082A in Patients Before and During Treatment With 1) MPDL3280A or 2) PD-1 Antibody Plus or Minus Ipilimumab
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center, single-arm, investigator sponsored trial designed to evaluate the PK of the anti-CD8 imaging agent in patients prior to and during treatment with checkpoint inhibitors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anti-CD8 PET imaging agent | An imaging agent radiolabelled with 89Zr developed for in human PET imaging of CD8 |
Timeline
- Start date
- 2019-02-14
- Primary completion
- 2022-12-28
- Completion
- 2024-12-01
- First posted
- 2019-07-23
- Last updated
- 2024-05-03
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04029181. Inclusion in this directory is not an endorsement.